Trisomy 8 in acute myeloblastic leukemia and sideroachrestic anemia.
D000368:Aged; D000750:Anemia, Myelophthisic / Q000235:genetics*; D000756:Anemia, Sideroblastic / Q000188:drug therapy / Q000235:genetics*; D001856:Bone Marrow Examination; D002478:Cells, Cultured; D002906:Chromosomes, Human, 6-12 and X; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007621:Karyotyping; D037102:Lectins / Q000494:pharmacology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D007962:Leukocytes / Q000166:cytology; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011732:Pyridoxal Phosphate / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use; D014314:Trisomy
D037102:Lectins; D003561:Cytarabine; D011732:Pyridoxal Phosphate; D005492:Folic Acid; D011239:Prednisolone; D013866:Thioguanine; D011736:Pyridoxine; D003630:Daunorubicin